Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 19
MDL Judge Breaks from Plan, Remands 'Extraordinary' Vioxx Suit
Merck Files Petition to Appeal Order Remanding Vioxx Action
N.J. Judge Sets Timeline, Parameters for Next Series of Vioxx Trials
Arthritis Drugs - Issue: 18
Arthritis Drugs In the Medical Literature This Month
Arthritis Drugs - Issue: 19
Judge Issues Rulings on In Limine Motions in Federal Vioxx Case
Merck Moves to Shrink Size of California Vioxx Proceedings by One Half
Judge Issues Daubert, Related Rulings Ahead of 1st Federal Trial
Court Refuses to Reconsider Decision Dismissing Bextra Case
